{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:56:05Z","timestamp":1788198965359,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijbiomac.2022.05.181","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T01:39:23Z","timestamp":1654479563000},"page":"728-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Biosynthesized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) as biocompatible microcapsules with extended release for busulfan and montelukast"],"prefix":"10.1016","volume":"213","author":[{"given":"Mohammad I.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Alsafadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eid","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Aboulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alamry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0005","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.leu.2402193","article-title":"The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro","volume":"15","author":"Hassan","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0010","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1200\/JCO.1986.4.12.1804","article-title":"High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study","volume":"4","author":"Hartmann","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0015","first-page":"12","article-title":"The development of busulfan\/cyclophosphamide preparative regimens","volume":"20","author":"Santos","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1517\/17425255.2013.737319","article-title":"Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan","volume":"9","author":"Galaup","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2008.12.489","article-title":"Busulfan in hematopoietic stem cell transplantation","volume":"15","author":"Ciurea","year":"2009","journal-title":"Biol. Blood Marrow. Transplant."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114216","article-title":"Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: validation of assay performance in the presence of drug formulation excipients","volume":"203","author":"Andersen","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0035","first-page":"135","article-title":"Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children","volume":"10","author":"M\u00e9resse","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"Grochow","year":"1989","journal-title":"Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1704275","article-title":"In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)","volume":"32","author":"Bouligand","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0050","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.ejca.2012.05.020","article-title":"Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1\/SIOPEN trial","volume":"48","author":"Veal","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002800050404","article-title":"Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy","volume":"37","author":"Bhagwatwar","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0731-7085(86)80027-9","article-title":"Degradation of busulfan in aqueous solution","volume":"4","author":"Hassan","year":"1986","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40268-013-0003-y","article-title":"Physico-chemical stability of busulfan in injectable solutions in various administration packages","volume":"13","author":"Houot","year":"2013","journal-title":"Drugs R D"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1039\/C5TB02084K","article-title":"Antineoplastic busulfan encapsulated in a metalorganic framework nanocarrier: first in vivo results","volume":"4","author":"Simon-Yarza","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0075","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/nnm.11.69","article-title":"Porous metal organic framework nanoparticles to address the challenges related to busulfan encapsulation","volume":"6","author":"Chalati","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/02652040701500905","article-title":"Busulphan-loaded long-circulating nanospheres, a very attractive challenge for both galenists and pharmacologists","volume":"24","author":"Bouligand","year":"2007","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jbm.b.30536","article-title":"Busulfan loading into poly(alkyl cyanoacrylate) nanoparticles: physico-chemistry and molecular modeling","volume":"79","author":"Layre","year":"2006","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0090","first-page":"11","article-title":"Cytotoxicity of cyanoacrylate-based tissue adhesives and short-term preclinical in vivo biocompatibility in abdominal hernia repair","volume":"20","author":"Pascual","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.progpolymsci.2017.05.002","article-title":"Advances in drug delivery systems based on synthetic poly(hydroxybutyrate) (co)polymers","volume":"73","author":"Barouti","year":"2017","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10924-020-01946-x","article-title":"Properties and Applications of Poly(3\u2011hydroxybutyrate\u2011co\u20113\u2011hydroxyvalerate) Biocomposites","author":"Ibrahim","year":"2021","journal-title":"J. Polym. Environ."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfa.2008.04.003","article-title":"Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent","volume":"324","author":"Poletto","year":"2008","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2016.08.066","article-title":"Preparation and characterization of biodegradable polyhydroxybutyrate-co-hydroxyvalerate\/polyethylene glycol-based microspheres","volume":"513","author":"Monnier","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jddst.2019.02.007","article-title":"Poly(-3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): current advances in synthesis methodologies, antitumor applications and biocompatibility","volume":"51","author":"Tebaldi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0120","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1590\/S0103-50532008000700011","article-title":"Physicochemical characterization of a hydrophilic model drug-loaded PHBV microparticles obtained by the double emulsion\/solvent evaporation technique","volume":"19","author":"Farago","year":"2008","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2005.05.019","article-title":"Preparation, characterization and in vitro release of gentamicin from PHBV\/wollastonite composite microspheres","volume":"107","author":"Li","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0130","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.polymdegradstab.2010.05.022","article-title":"Encapsulation and release of biomolecules from Ca-P\/PHBV nanocomposite microspheres and three-dimensional scaffolds fabricated by selective laser sintering","volume":"95","author":"Duan","year":"2010","journal-title":"Polym. Degrad. Stab."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0135","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.msec.2009.05.015","article-title":"A novel PHBV\/HA microsphere releasing system loaded with alendronate","volume":"29","author":"Huang","year":"2009","journal-title":"Mater. Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0140","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S1003-6326(11)61035-2","article-title":"Preparation and characterization of icariin\/PHBV drug delivery coatings on anodic oxidized titanium","volume":"21","author":"Dai","year":"2011","journal-title":"Trans. Nonferrous Met. Soc. China"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0145","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.msec.2013.04.050","article-title":"Icariin delivery porous PHBV scaffolds for promoting osteoblast expansion in vitro","volume":"33","author":"Xia","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jeurceramsoc.2013.08.032","article-title":"Preparation and characterization of vancomycin releasing PHBV 45S5 bioglass\u2013based glass-ceramic scaffolds for bone tissue engineering","volume":"34","author":"Li","year":"2014","journal-title":"J. Eur. Ceram. Soc."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.msec.2014.04.052","article-title":"Preparation and characterization of PHBV microsphere\/45S5 bioactive glass composite scaffolds with vancomycin releasing function","volume":"41","author":"Li","year":"2014","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2019.110004","article-title":"Formulation and characterization of a novel PHBV nanocomposite for bone defect filling and infection treatment","volume":"104","author":"De Almeida Neto","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.msec.2019.03.046","article-title":"Diatom shell incorporated PHBV\/PCL-pullulan co-electrospun scaffold for bone tissue engineering","volume":"100","author":"Dalgic","year":"2019","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0170","article-title":"Preparation and characterization of dry powder containing sunitinib loaded PHBV nanoparticles for enhanced pulmonary delivery","volume":"56","author":"Otroj","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0175","first-page":"110","article-title":"Poly(hydroxybutyrate-co-hydroxyvalerate) microparticles embedded in \u03ba-carrageenan\/locust bean gum hydrogel as a dual drug delivery carrier","volume":"146","author":"Pettinelli","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0180","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijbiomac.2018.09.119","article-title":"Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)\/poly (lactic-co-glycolic acid) nanoparticles for colon cancer therapy","volume":"124","author":"Handali","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0883911516635839","article-title":"Synthesis and characterization of polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for encapsulation of quercetin","volume":"31","author":"Lightfoot","year":"2016","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118519","article-title":"Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: preparation, characterization and evaluation of ophthalmic toxicity","volume":"568","author":"\u00c1lvarez-\u00c1lvarez","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0195","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijbiomac.2017.10.172","article-title":"Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles- a synergistic approach","volume":"108","author":"Vardhan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijbiomac.2019.12.049","article-title":"Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles","volume":"144","author":"Perveen","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2225\/vol16-issue5-fulltext-8","article-title":"Superparamagnetic poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles for biomedical applications","volume":"16","author":"Vilos","year":"2013","journal-title":"Electron. J. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jmmm.2015.01.005","article-title":"Core\u2013shell composite particles composed of biodegradable polymer particles and magnetic iron oxide nanoparticles for targeted drug delivery","volume":"381","author":"Oka","year":"2015","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.139716","article-title":"Utilizing the crop waste of date palm fruit to biosynthesize polyhydroxyalkanoate bioplastics with favorable properties","volume":"737","author":"Alsafadi","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbt.2016.05.003","article-title":"A one-stage cultivation process for the production of poly-3-(hydroxybutyrate-cohydroxyvalerate) from olive mill wastewater by Haloferax mediterranei","volume":"34","author":"Alsafadi","year":"2017","journal-title":"New Biotechnol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0225","series-title":"Strategies to Modify the Drug Release From Pharmaceutical Systems","first-page":"63","article-title":"Mathematical models of drug release","author":"Bruschi","year":"2015"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s12221-012-0692-9","article-title":"Electrospinning of PHBV\/ZnO membranes: structure and properties","volume":"13","author":"Naphade","year":"2012","journal-title":"Fibers Polym."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0235","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.saa.2016.09.031","article-title":"Characterization and intramolecular bonding patterns of busulfan: experimental and quantum chemical approach","volume":"173","author":"Karthick","year":"2017","journal-title":"Spectrochim. Acta A Mol."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0240","first-page":"125","article-title":"Preparation and evaluation of montelukast sodium chewable tablets using modified karaya gum","volume":"4","author":"Shruthi","year":"2013","journal-title":"J. Pelagia Res.Libr.DerPharmacia Sin."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0245","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/pen.23084","article-title":"Mechanical and electrical multifunctional poly(3-hydroxybutyrate-co-3-hydroxyvalerate)\u2014multiwall carbon nanotube nanocomposites","volume":"52","author":"Vidhate","year":"2012","journal-title":"Polym. Eng. Sci."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0250","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijpharm.2017.11.007","article-title":"Development and characterization of an organic solvent free, proliposomal formulation of busulfan using quality by design approach","volume":"535","author":"Chobisa","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0255","first-page":"91","article-title":"Particulate matter in injectable drugs: evaluation of risks to patients","volume":"1","author":"Perez","year":"2016","journal-title":"Pharm. Technol. Hosp. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0260","series-title":"The European Pharmacopoeia","article-title":"General, particulate contamination: sub-visible particles","year":"2016"},{"key":"10.1016\/j.ijbiomac.2022.05.181_bb0265","first-page":"202","article-title":"Quality-control analytical methods: particulate matter in injections: what is it and what are the concerns?","volume":"10","author":"Tran","year":"2006","journal-title":"Int. J. Pharm. Compd."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022011722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022011722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:38:14Z","timestamp":1758879494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022011722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":53,"alternative-id":["S0141813022011722"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.05.181","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biosynthesized poly(3-hydroxybutyrate-co-3-hydroxyvalerate) as biocompatible microcapsules with extended release for busulfan and montelukast","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.05.181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}